These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 34036383

  • 1. Long non‑coding RNA PCED1B‑AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR‑411‑3p/HIF‑1α axis.
    Zhang Y, Ma H, Chen C.
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036383
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X, Liu Y, Li Z, Zheng S, Wang Z, Li W, Bi Z, Li L, Jiang Y, Luo Y, Lin Q, Fu Z, Rufu C.
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [Abstract] [Full Text] [Related]

  • 4. LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis.
    Wang W, Li X, Guan C, Hu Z, Zhao Y, Li W, Jiang X.
    Pathol Res Pract; 2020 Sep; 216(9):153074. PubMed ID: 32825947
    [Abstract] [Full Text] [Related]

  • 5. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
    Sun Y, Zhu Q, Yang W, Shan Y, Yu Z, Zhang Q, Wu H.
    J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1α in pancreatic ductal adenocarcinoma.
    Sun YW, Chen YF, Li J, Huo YM, Liu DJ, Hua R, Zhang JF, Liu W, Yang JY, Fu XL, Yan T, Hong J, Cao H.
    Br J Cancer; 2014 Nov 25; 111(11):2131-41. PubMed ID: 25314054
    [Abstract] [Full Text] [Related]

  • 9. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD, Fu ZQ, Lin Q, Zhou Y, Zhou QB, Li ZH, Tan LP, Chen RF, Liu YM.
    World J Gastroenterol; 2015 Aug 21; 21(31):9348-57. PubMed ID: 26309360
    [Abstract] [Full Text] [Related]

  • 10. CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing.
    Shen P, Yang T, Chen Q, Yuan H, Wu P, Cai B, Meng L, Huang X, Liu J, Zhang Y, Hu W, Miao Y, Lu Z, Jiang K.
    Mol Cancer; 2021 Mar 09; 20(1):51. PubMed ID: 33750389
    [Abstract] [Full Text] [Related]

  • 11. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y, Liu X, Chen Q, Liu T, Lu C, Yu J, Miao Y, Wei J.
    J Exp Clin Cancer Res; 2018 Jul 03; 37(1):130. PubMed ID: 29970191
    [Abstract] [Full Text] [Related]

  • 12. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.
    Xu C, Qi X.
    J Clin Lab Anal; 2020 Oct 03; 34(10):e23442. PubMed ID: 32592206
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1.
    Li S, Yan G, Yue M, Kang Z, Wang L.
    Mol Med Rep; 2019 Feb 03; 19(2):1380-1387. PubMed ID: 30569091
    [Abstract] [Full Text] [Related]

  • 14. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F, Guo T, Cao C.
    Dig Dis Sci; 2020 Oct 03; 65(10):2844-2852. PubMed ID: 31853782
    [Abstract] [Full Text] [Related]

  • 15. Long noncoding RNA DLEU1 aggravates pancreatic ductal adenocarcinoma carcinogenesis via the miR-381/CXCR4 axis.
    Gao S, Cai Y, Zhang H, Hu F, Hou L, Xu Q.
    J Cell Physiol; 2019 May 03; 234(5):6746-6757. PubMed ID: 30382579
    [Abstract] [Full Text] [Related]

  • 16. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b.
    Yang H, Liu P, Zhang J, Peng X, Lu Z, Yu S, Meng Y, Tong WM, Chen J.
    Oncogene; 2016 Jul 14; 35(28):3647-57. PubMed ID: 26549028
    [Abstract] [Full Text] [Related]

  • 17. MKLN1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1α through miR-185-5p/TEAD1 pathway.
    Chen J, Li L, Feng Y, Zhao Y, Sun F, Zhou X, Yiqi D, Li Z, Kong F, Kong X.
    Cell Biol Toxicol; 2024 May 13; 40(1):30. PubMed ID: 38740637
    [Abstract] [Full Text] [Related]

  • 18. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer.
    Takahashi K, Ota Y, Kogure T, Suzuki Y, Iwamoto H, Yamakita K, Kitano Y, Fujii S, Haneda M, Patel T, Ota T.
    Cancer Sci; 2020 Jan 13; 111(1):98-111. PubMed ID: 31715081
    [Abstract] [Full Text] [Related]

  • 19. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
    Guo X, Zhou Q, Su D, Luo Y, Fu Z, Huang L, Li Z, Jiang D, Kong Y, Li Z, Chen R, Chen C.
    Mol Cancer; 2020 May 06; 19(1):83. PubMed ID: 32375768
    [Abstract] [Full Text] [Related]

  • 20. lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP.
    Li N, Yang G, Luo L, Ling L, Wang X, Shi L, Lan J, Jia X, Zhang Q, Long Z, Liu J, Hu W, He Z, Liu H, Liu W, Zheng G.
    Clin Cancer Res; 2020 Apr 01; 26(7):1736-1748. PubMed ID: 31831555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.